Literature DB >> 8449376

Muscle performance and gross motor function of children with spastic cerebral palsy.

D F Parker1, L Carriere, H Hebestreit, A Salsberg, O Bar-Or.   

Abstract

The purpose of this study was to determine whether, and to what extent, performance on a measure of motor function (Gross Motor Function Measure, GMFM) was related to the physiological fitness of children with cerebral palsy (CP). Two elements of physiological function were measured: aerobic power and anaerobic power of the arms and legs. 15 boys and eight girls aged between seven and 13.9 years with spastic CP participated in the study. There was a good relationship between the standing and walking, running and jumping sub-sections and the total score of the GMFM on one hand, and anaerobic capacity of the legs on the other. However, the relationships for the arms were limited, indicating that the GMFM is not a suitable tool for providing information about aerobic fitness in children with CP, or about anaerobic power of the arms.

Entities:  

Mesh:

Year:  1993        PMID: 8449376     DOI: 10.1111/j.1469-8749.1993.tb11547.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  3 in total

1.  Anaerobic power and muscle strength in human immunodeficiency virus-positive preadolescents.

Authors:  Edwardo Ramos; Suzanne Guttierrez-Teissoonniere; Jose G Conde; Jose A Baez-Cordova; Brenda Guzman-Villar; Edgar Lopategui-Corsino; Walter R Frontera
Journal:  PM R       Date:  2012-02-23       Impact factor: 2.298

Review 2.  Evaluation by exercise testing of the child with cerebral palsy.

Authors:  V B Unnithan; C Clifford; O Bar-Or
Journal:  Sports Med       Date:  1998-10       Impact factor: 11.136

3.  Comparative study of skin folding of dominant and nondominant hemibodies in spastic hemiplegic cerebral palsy.

Authors:  Osmair Gomes de Macedo; João Gilberto Carazzato; Eduardo de Souza Meirelles; Adilson de Paula; Carlos Alberto Dos Santos; Raul Bolliger Neto; Rames Mattar Júnior
Journal:  Clinics (Sao Paulo)       Date:  2008-10       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.